AG
RARE icon

Algert Global’s Ultragenyx Pharmaceutical RARE Stock Holding History

Algert Global’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Sell
389,964
-38,565
-9% -$958K 0.15% 194
2026
Q1 		$8.98M Buy
428,529
+209,297
+95% +$4.71M 0.14% 238
2025
Q4 		$5.04M Sell
219,232
-102,401
-32% -$3.37M 0.08% 432
2025
Q3 		$9.67M Buy
321,633
+205,286
+176% +$6.16M 0.16% 197
2025
Q2 		$4.23M Sell
116,347
-13,973
-11% -$504K 0.09% 385
2025
Q1 		$4.72M Buy
130,320
+47,527
+57% +$1.98M 0.12% 295
2024
Q4 		$3.48M Buy
82,793
+8,891
+12% +$441K 0.08% 411
2024
Q3 		$4.11M Buy
73,902
+23,580
+47% +$1.2M 0.11% 321
2024
Q2 		$2.07M Buy
50,322
+25,752
+105% +$1.1M 0.07% 457
2024
Q1 		$1.15M Hold
24,570
– – 0.04% 580
2023
Q4 		$1.17M Buy
24,570
+2,430
+11% +$94.2K 0.05% 577
2023
Q3 		$789K Sell
22,140
-4,710
-18% -$187K 0.04% 618
2023
Q2 		$1.24M Sell
26,850
-11,910
-31% -$552K 0.05% 578
2023
Q1 		$1.55M Buy
+38,760
New +$1.66M 0.07% 431
2022
Q2 		– Sell
-3,061
Closed -$222K – 1348
2022
Q1 		$222K Sell
3,061
-1,392
-31% -$96.9K 0.01% 1023
2021
Q4 		$374K Sell
4,453
-1,800
-29% -$146K 0.05% 650
2021
Q3 		$564K Buy
+6,253
New +$565K 0.08% 494

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Algert Global's RARE Position: Q2 2026 in Review

Algert Global reduced its Ultragenyx Pharmaceutical (RARE) stake by 9% in Q2 2026, selling an estimated $958K and leaving 389,964 shares worth $13M. The position accounts for 0.15% of the portfolio, ranked #194.

Algert Global first reported a position in RARE in Q3 2021 and has held it in 17 quarters since. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Algert Global held 389,964 shares of Ultragenyx Pharmaceutical worth $13M as of Q2 2026.
  • Algert Global sold 38,565 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $958K.
  • Ultragenyx Pharmaceutical made up 0.15% of Algert Global's portfolio in Q2 2026, its #194 holding.
  • Algert Global first reported a position in Ultragenyx Pharmaceutical in Q3 2021 and has held it in 17 quarters since.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.